InvestorsHub Logo

surf1944

10/31/11 8:41 AM

#42 RE: surf1944 #41

7:02AM Auxilium Pharma beats by $0.12, reports revs in-line (AUXL) 17.22 : Reports Q3 (Sep) loss of $0.08 per share, $0.12 better than the Capital IQ Consensus Estimate of ($0.20); revenues rose 24.4% year/year to $66.7 mln vs the $66.8 mln consensus. As of September 30, 2011, co had $149.6 mln in cash and cash equivalents compared to $151.8 mln on June 30, 2011.